Otsuka Holdings Co (JP:4578) has released an update.
Otsuka Holdings Co., Ltd. has updated its first-half FY2024 financial forecast, showing an improvement due to strong performance, particularly in its pharmaceutical and nutraceutical businesses. Key products driving profits include REXULTI, LONSURF, ABILIFY MAINTENA, JYNARQUE, and POCARI SWEAT. The upward revision also reflects lower than anticipated selling, general, and R&D expenses, with the company set to announce its full-year forecast on August 1st, 2024.
For further insights into JP:4578 stock, check out TipRanks’ Stock Analysis page.
